In close collaboration with clinical researchers Enzymatica develops medical devices for upper respiratory tract infections and oral health. 

Enzymatica develops innovative products by combining experience and knowledge from previous projects. To reduce time to market, development costs and risk, development is on the same technology platform as Enzymatica’s common cold product ColdZyme®. After the acquisition of Zymetech Enzymatica has strengthened its team of scientists.